In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop. There is also much evidence that these three diseases are ...

In experimental models, a team led by Aphrodite Kapurniotu, Professor of Peptide Biochemistry at TUM, has now succeeded in inhibiting the formation of protein aggregates in Parkinson's disease ...